The combination of antifibrotic therapy and pulmonary vasodilator therapy improved transplant-free survival but had no ...

Gradient Denervation Technologies announced today that it received FDA breakthrough device designation for its denervation ...

The following is a summary of "Prognostic value of non-invasive right ventricle-pulmonary artery coupling in patients with ...

Cardiac output and stroke volume as measured by impedance cardiography may hold potential to predict clinical deterioration ...

Foresee Pharma begins patient dosing in phase 2 WINDWARD study of mirivadelgat to treat pulmonary hypertension-associated interstitial lung disease: Taipei, Taiwan Friday, May 16, ...

Gradient Denervation Technologies announced today the company’s pulmonary denervation system has received Breakthrough Device ...

Gradient Denervation Technologies, which is based in Paris, France, announced that the company’s pulmonary artery denervation ...

Research has found that drinking beetroot (beet) juice daily can help lower blood pressure. Here’s why and how you can drink ...

This is a critical time in the fight to protect health care access and affordability for everyone.” That’s what Healthy Wyoming Interim Executive Director Jenn Lowe said during a webinar Thursday ...

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the therapeutics industry, ...

Fintel reports that on May 19, 2025, Oppenheimer downgraded their outlook for Liquidia (NasdaqCM:LQDA) from Perform to ...

Earlier this afternoon, Gossamer Bio issued a press release announcing its first-quarter 2025 financial results and provided a corporate update. Please note that certain information discussed on the ...